Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid. 2011

Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
Department of Virology, Haartman Institute, University of Helsinki, Finland. virtanenjo@ninds.nih.gov

Demyelinating diseases of the central nervous system (CNS) often include elevated IgG production in intrathecal space presenting as oligoclonal bands (OCBs) in cerebrospinal fluid (CSF). In most demyelinating diseases, e.g. in multiple sclerosis (MS), the underlying cause is not known. We used isoelectric focusing and affinity immunoblot to study the specificity of CSF OCBs to human herpesvirus-6 (HHV-6) in patients with demyelinating diseases of the CNS including MS. Eighty patients with positive OCB finding were included in the study. The OCBs reacted with the HHV-6 antigen in 18 cases (23%). Twelve of 46 MS patients (26%), 5 of 24 other demyelinating diseases (21%) and 1 of 10 other neurological disorders (10%) had HHV-6 specific OCBs in CSF. A specific intrathecal HHV-6 A and B antibody production was shown in a proportion of patients with demyelinating diseases and might suggest a role in the pathogenesis of these diseases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009185 Myelin Proteins MYELIN-specific proteins that play a structural or regulatory role in the genesis and maintenance of the lamellar MYELIN SHEATH structure. Myelin Protein,Protein, Myelin,Proteins, Myelin
D009413 Nerve Fibers, Myelinated A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the myelinated nerve fibers are completely encased in a MYELIN SHEATH. They are fibers of relatively large and varied diameters. Their NEURAL CONDUCTION rates are faster than those of the unmyelinated nerve fibers (NERVE FIBERS, UNMYELINATED). Myelinated nerve fibers are present in somatic and autonomic nerves. A Fibers,B Fibers,Fiber, Myelinated Nerve,Fibers, Myelinated Nerve,Myelinated Nerve Fiber,Myelinated Nerve Fibers,Nerve Fiber, Myelinated
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
January 2011, Journal of neuroimmunology,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
December 1986, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
January 2004, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
April 2023, Annals of translational medicine,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
July 2007, European journal of neurology,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
April 2008, European journal of neurology,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
January 1980, American journal of clinical pathology,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
January 2015, BioMed research international,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
February 2020, Journal of neuroimmunology,
Jussi O Virtanen, and Jenna Pietiläinen-Nicklén, and Lasse Uotila, and Markus Färkkilä, and Antti Vaheri, and Marjaleena Koskiniemi
January 1983, Annals of neurology,
Copied contents to your clipboard!